Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Olmesartan Medoxomil 40 mg vs Benicar 40 mg in Healthy Subjects
NCT03318354Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- May 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of olmesartan in hypertension (HTN) (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started May 2010; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03318354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318354.